Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2003 | 03-2002 | 03-2001 | 03-2000 | 03-1999 | |
| Sales | 19,541 | 19,006 | 12,400 | 12,774 | 14,064 |
| Cost of Goods | 12,292 | 11,839 | 9,701 | 8,995 | 9,768 |
| Gross Profit | 7,249 | 7,167 | 2,699 | 3,779 | 4,296 |
| Operating Expenses | 7,989 | 7,889 | 6,496 | 7,006 | 7,512 |
| Operating Income | -448 | 117 | -3,096 | -2,231 | -2,448 |
| Other Income | 20 | 50 | 87 | 43 | 41 |
| Pre-tax Income | -428 | 167 | -3,009 | -2,188 | -2,407 |
| Income Tax | 5 | -990 | 2 | 323 | -943 |
| Net Income Continuous | -433 | 1,157 | -3,011 | -2,511 | -1,464 |
| Net Income | $-433 | $1,157 | $-3,011 | $-2,511 | $-1,464 |
| EPS Basic Total Ops | -0.04 | 0.12 | -0.30 | -0.25 | -0.15 |
| EPS Basic Continuous Ops | -0.04 | 0.12 | -0.30 | -0.25 | -0.15 |
| EPS Diluted Total Ops | -0.04 | 0.11 | -0.30 | -0.25 | -0.15 |
| EPS Diluted Continuous Ops | -0.04 | 0.11 | -0.30 | -0.25 | -0.15 |
| EBITDA(a) | $320 | $1,019 | $-2,187 | $-1,338 | $-1,554 |